Influence of fruit juices on drug disposition:: discrepancies between in vitro and clinical studies

被引:59
作者
Farkas, Dora
Greenblatt, David J. [1 ]
机构
[1] Tufts Univ, Sch Med, Dept Pharmacol & Expt Therapeut, Boston, MA 02111 USA
关键词
6'7'-dihydroxybergamottin; cranberry; furanocoumarins; grapefruit; orange; pomegranate;
D O I
10.1517/17425255.4.4.381
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: Grapefruit juice is known to alter the pharmacokinetics of over 30 prescription drugs by increasing their bioavailabilities. After the discovery of this interaction almost 20 years ago, there have been many reports investigating the effects of fruit juices on drug disposition. Objective: This article reviews the literature on fruit juice-prescription drug interaction studies to determine which juices are likely to cause clinically significant interactions. Methods: We examined the results from in vitro and clinical studies regarding the interactions between prescription drugs and over ten fruit beverages. Results/conclusions: Grapefruit juice and Seville orange juice caused several clinically significant interactions with cytochrome P4503A (CYP3A). The OATP drug transporter was inhibited by grapefruit juice, orange juice, and apple juice. Other fruit juices also interacted with drug metabolizing enzymes and transporters in vitro, but more studies are needed to determine whether these interactions are clinically significant.
引用
收藏
页码:381 / 393
页数:13
相关论文
共 109 条
[1]   Dietary catechins in relation to coronary heart disease death among postmenopausal women [J].
Arts, ICW ;
Jacobs, DR ;
Harnack, LJ ;
Gross, M ;
Folsom, AR .
EPIDEMIOLOGY, 2001, 12 (06) :668-675
[2]  
Aviram M, 2002, DRUG EXP CLIN RES, V28, P49
[3]   Pomegranate juice consumption inhibits serum angiotensin converting enzyme activity and reduces systolic blood pressure [J].
Aviram, M ;
Dornfeld, L .
ATHEROSCLEROSIS, 2001, 158 (01) :195-198
[4]  
Aviram M, 2000, AM J CLIN NUTR, V71, P1062
[5]   Lack of correlation between in vitro and in vivo studies on the effects of tangeretin and tangerine juice on midazolam hydroxylation [J].
Backman, JT ;
Mäenpää, J ;
Belle, DJ ;
Wrighton, SA ;
Kivistö, KT ;
Neuvonen, PJ .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2000, 67 (04) :382-390
[6]   Naringin is a major and selective clinical inhibitor of organic anion-transporting polypeptide 1A2 (OATP1A2) in grapefruit juice [J].
Bailey, D. G. ;
Dresser, G. K. ;
Leake, B. F. ;
Kim, R. B. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 (04) :495-502
[7]   Interactions between grapefruit juice and cardiovascular drugs [J].
Bailey D.G. ;
Dresser G.K. .
American Journal of Cardiovascular Drugs, 2004, 4 (5) :281-297
[8]   Grapefruit juice-drug interactions (Reprinted from Br J Clin Pharmacol, vol 46, pg 101-110, 1998) [J].
Bailey, DG ;
Malcolm, J ;
Arnold, O ;
Spence, JD .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 58 (07) :S831-S840
[9]   Bergamottin, lime juice, and red wine as inhibitors of cytochrome P450 3A4 activity: Comparison with grapefruit juice [J].
Bailey, DG ;
Dresser, GK ;
Bend, JR .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 73 (06) :529-537
[10]  
BAILEY DG, 1989, CLIN INVEST MED, V12, P357